InMed Pharmaceuticals, Inc. (INM)
1.44
+0.11
(+8.27%)
USD |
NASDAQ |
Oct 23, 16:00
1.54
+0.10
(+6.94%)
After-Hours: 20:00
InMed Pharmaceuticals Price : 1.44 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.320 | 1.54 | 1.32 | 1.44 | 125918.0 |
| Oct 22, 2026 | 1.36 | 1.375 | 1.33 | 1.33 | 8293.00 |
| Oct 21, 2026 | 1.32 | 1.390 | 1.32 | 1.36 | 27191.00 |
| Oct 20, 2026 | 1.345 | 1.389 | 1.34 | 1.34 | 38307.00 |
| Oct 19, 2026 | 1.32 | 1.39 | 1.32 | 1.365 | 38467.00 |
| Oct 16, 2026 | 1.32 | 1.34 | 1.32 | 1.32 | 4360.00 |
| Oct 15, 2026 | 1.31 | 1.34 | 1.31 | 1.33 | 17595.00 |
| Oct 14, 2026 | 1.35 | 1.36 | 1.31 | 1.31 | 31329.00 |
| Oct 13, 2026 | 1.34 | 1.365 | 1.33 | 1.33 | 28239.00 |
| Oct 12, 2026 | 1.39 | 1.40 | 1.36 | 1.36 | 28776.00 |
| Oct 09, 2026 | 1.35 | 1.44 | 1.35 | 1.36 | 56128.00 |
| Oct 08, 2026 | 1.32 | 1.355 | 1.32 | 1.33 | 28001.00 |
| Oct 07, 2026 | 1.35 | 1.35 | 1.33 | 1.33 | 19998.00 |
| Oct 06, 2026 | 1.38 | 1.38 | 1.32 | 1.33 | 18302.00 |
| Oct 05, 2026 | 1.36 | 1.39 | 1.33 | 1.33 | 29768.00 |
| Oct 02, 2026 | 1.370 | 1.385 | 1.33 | 1.33 | 28338.00 |
| Oct 01, 2026 | 1.34 | 1.370 | 1.32 | 1.35 | 99970.00 |
| Sep 30, 2026 | 1.35 | 1.410 | 1.34 | 1.36 | 60668.00 |
| Sep 29, 2026 | 1.35 | 1.42 | 1.34 | 1.375 | 60531.00 |
| Sep 28, 2026 | 1.364 | 1.37 | 1.36 | 1.36 | 17395.00 |
| Sep 25, 2026 | 1.38 | 1.40 | 1.35 | 1.38 | 101106.0 |
| Sep 24, 2026 | 1.39 | 1.42 | 1.37 | 1.40 | 38964.00 |
| Sep 23, 2026 | 1.39 | 1.41 | 1.375 | 1.38 | 53681.00 |
| Sep 22, 2026 | 1.39 | 1.442 | 1.37 | 1.39 | 38336.00 |
| Sep 21, 2026 | 1.375 | 1.46 | 1.37 | 1.38 | 120104.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 1.43 |
| Milestone Pharmaceuticals, Inc. | 0.6482 |
| Appili Therapeutics, Inc. | 0.0068 |
| Clearmind Medicine, Inc. | 5.87 |
| Lexaria Bioscience Corp. | 3.08 |
Price Related Metrics
| PS Ratio | 3.030 |
| Price to Book Value | 7.152 |
| Earnings Yield | -216.4% |
| Market Cap | 7.689M |